Trinity Biotech to Report Second Quarter 2024 Financial Results

Strategic Insights -

Trinity Biotech plc, a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, will report its financial results for the second quarter 2024 on Wednesday, August 14, 2024. This announcement comes as the company continues to expand its product offerings, including wearable biosensors, and enters the wearable biosensor industry with the acquisition of Waveform Technologies Inc.'s biosensor assets. As a global player in the diagnostic market, Trinity Biotech sells its products directly in the US, Germany, France, and the UK, and through a network of international distributors and strategic partners in over 75 countries worldwide.

Key Takeaways:

  • Trinity Biotech will report its second quarter 2024 financial results on Wednesday, August 14, 2024 at 8:30 AM ET.
  • The company has recently entered the wearable biosensor industry with the acquisition of the biosensor assets of Waveform Technologies Inc.
  • Trinity Biotech develops, acquires, manufactures, and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market.
  • The company has over 75 countries worldwide where it sells its products directly or through a network of international distributors and strategic partners.
  • Trinity Biotech has entered the wearable biosensor market with a focus on developing a range of biosensor devices and related services, starting with a continuous glucose monitoring product.
  • The company sells its products in the US, Germany, France, and the UK directly, and through international distributors and strategic partners elsewhere.

Statistics:

  • Trinity Biotech will report its second quarter 2024 financial results on August 14, 2024.
  • The company has over 75 countries worldwide where it sells its products.
  • Trinity Biotech has a global presence in the US, Germany, France, and the UK, as well as internationally through a network of distributors and partners.
  • The company has recently entered the wearable biosensor industry.

Sources:

  • GlobeNewswire (GLOBE NEWSWIRE) dated August 13, 2024
  • Trinity Biotech plc (NASDAQ: TRIB)